 |
 |
 |
 |
Journal articles
Involvement of BCL2 family members in the regulation of human oocyte and early embryo survival and death: gene expression and beyond
Abstract : In women, up to 99.9% of the oocyte stockpile formed during fetal life is decimated by apoptosis. Apoptotic features are also detected in human preimplantation embryos both in vivo and in vitro. Despite the important consequences of cell death processes to oocyte competence and early embryonic development, little is known about its genetic and molecular control. B cell lymphoma-2 (BCL2) family proteins are major regulators of cell death and survival. Here, we present a literature review on BCL2 family expression and protein distribution in human and animal oocytes and early embryos. Most of the studies focused on the expression of two antagonistic members: the founding and survival family member BCL2 and its proapoptotic homolog BAX. However, recent transcriptomic analyses have identified novel candidate genes related to oocyte and/or early embryonic viability (such as BCL2L10) or commitment to apoptosis (e.g. BIK). Interestingly, some BCL2 proteins appear to be differentially distributed at the subcellular level during oocyte maturation and early embryonic development, a process probably linked to the functional compartmentalization of the ooplasm and blastomere. Assessment of BCL2 family involvement in regulating the survival of human oocytes and embryos may be of particular value for diagnosis and assisted reproductive technology. We suggest that implications of not only aberrant gene expression but also abnormal subcellular protein redistribution should be established in pathological conditions resulting in infertility.
https://hal-ens-lyon.archives-ouvertes.fr/ensl-00808957
Contributor : Agnès Ganivet Connect in order to contact the contributor
Submitted on : Monday, April 8, 2013 - 11:54:46 AM
Last modification on : Tuesday, March 15, 2022 - 9:38:03 AM
Contributor : Agnès Ganivet Connect in order to contact the contributor
Submitted on : Monday, April 8, 2013 - 11:54:46 AM
Last modification on : Tuesday, March 15, 2022 - 9:38:03 AM